Clinical Trial Update: Treatment of Spinal Cord Injury Using Autologous Concentrated Growth Factors [EARLY_Phase 1]

View source ↗

Summary

A not-yet-recruiting early-phase 1 clinical trial is evaluating autologous concentrated growth factors as a treatment for spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous Concentrated Growth Factors

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Spinal Cord Injury | EARLY_Phase 1 | Status: NOT_YET_RECRUITING